|
Breast Cancer Ultrasound Device Gets Favorable Panel Recommendation
An FDA advisory panel unanimously recommended approval of a new tool for detecting breast cancer, but advised against Class I status for a preamendment device used for the same purpose.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives